EP 1259546 A1 20021127 - CCR2-64I, POLYMORPHIC VARIANT OF THE HUMAN CCR2 RECEPTOR AND ITS USE IN THE DIAGNOSTIC AND TREATMENT OF ATHEROSCLEROSIS
Title (en)
CCR2-64I, POLYMORPHIC VARIANT OF THE HUMAN CCR2 RECEPTOR AND ITS USE IN THE DIAGNOSTIC AND TREATMENT OF ATHEROSCLEROSIS
Title (de)
CCR2-64I, POLYMORPHE-VARIANT DES MENSCHLICHEN CCR2-REZEPTORS UND IHRE VERWENDUNG IN DER DIAGNOSTIK UND BEHANDLUNG VON ATHEROSCLEROSE
Title (fr)
CCR2-64I, VARIANT POLYMORPHIQUE DU RECEPTEUR CCR2 HUMAIN ET UTILISATION DANS LE DIAGNOSTIC ET LE TRAITEMENT DE L'ATHEROSCLEROSE
Publication
Application
Priority
- GB 0100755 W 20010222
- GB 0004183 A 20000222
Abstract (en)
[origin: WO0162796A1] The invention relates to the human CCR2 receptor (CCR2-64V), in particular a polymorphic variant form of the human CCR2 receptor (CCR2-64I), and its involvement as a risk factor in the development of atherosclerosis. Variant CCR2 polynucleotides and polypeptides are provided together with methods for their use including screening and diagnostic methods in the development of atherosclerosis.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 9/10 (2006.01); C07K 14/705 (2006.01); C12N 15/09 (2006.01); C12Q 1/68 (2006.01); C12Q 1/6883 (2018.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); C12Q 1/6883 (2013.01); C12Q 2600/156 (2013.01)
Citation (search report)
See references of WO 0162796A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0162796 A1 20010830; AU 3393401 A 20010903; EP 1259546 A1 20021127; GB 0004183 D0 20000412; JP 2003523763 A 20030812
DOCDB simple family (application)
GB 0100755 W 20010222; AU 3393401 A 20010222; EP 01905970 A 20010222; GB 0004183 A 20000222; JP 2001562577 A 20010222